Hillary House
Psychiatric/Mental Health · Indianapolis, INNPI 1982046587
Payments from drug & device makers
Across 99 payments — averaging $26.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$727
- Supernus Pharmaceuticals, Inc.$576
- AbbVie$321
- Axsome Therapeutics, Inc.$227
- Vanda Pharmaceuticals Inc.$111
- Johnson & Johnson$96
- plus $548 from 15 others
What the payments were for
- Food & beverage$2,606100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 13 | $727 |
| Supernus Pharmaceuticals, Inc. | 15 | $576 |
| AbbVie | 20 | $321 |
| Axsome Therapeutics, Inc. | 14 | $227 |
| Vanda Pharmaceuticals Inc. | 4 | $111 |
| Johnson & Johnson | 4 | $96 |
| Noven Therapeutics, LLC | 4 | $89 |
| Corium, LLC | 4 | $75 |
| Teva Pharmaceuticals USA, Inc. | 2 | $63 |
| Otsuka America Pharmaceutical, Inc. | 3 | $52 |
| Neos Therapeutics, LP | 2 | $41 |
| OWP Pharmaceuticals, Inc. | 2 | $39 |
| Collegium Pharmaceutical, Inc. | 2 | $33 |
| Ironshore Pharmaceuticals Inc. | 2 | $29 |
| Vertical Pharmaceuticals, LLC | 2 | $28 |
| Neuronetics, Inc. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Novo Nordisk | 1 | $14 |
| Lundbeck LLC | 1 | $13 |
| Sunovion Pharmaceuticals Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$1,622
- LYBALVI$867
- QELBREE$284
- ARISTADA INITIO$243
How this compares
$2,606 in reported general payments places this provider in the 80th percentile of 729 psychiatric/mental health providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 14 | $352 |
| Buspirone Hcl | 12 | $263 |
| Duloxetine Hcl | 15 | $94 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Indianapolis
- Sonya RuedlingerIndianapolis$134K
- Devan GravesIndianapolis$12K
- Clyde YanIndianapolis$9K
- Beth DelamboIndianapolis$7K
- Olga Marie JiodioIndianapolis$6K
- Lindsay RussellIndianapolis$5K
- Nina VoigtIndianapolis$5K
- Brooke KempfTerre Haute$1.1M
- Gerald LewisMerrillville$336K
- Lauren LutzColumbus$320K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.